Related references
Note: Only part of the references are listed.ESC 2022 guidelines on cardio-oncology in collaboration with the European Hematology Association (EHA), European Society of Therapeutic Radiology and Oncology (ESTRO) and International Cardio-Oncology Society (IC- OS) developed by the Cardio-Oncology Task Force of the European Society of Cardiology (ESC)
Alexander R. Lyon et al.
GIORNALE ITALIANO DI CARDIOLOGIA (2023)
Cardio-Oncology Drug Interactions: A Scientific Statement From the American Heart Association
Craig J. Beavers et al.
CIRCULATION (2022)
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary
Paul A. Heidenreich et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)
Cardiovascular Disease Risk Among Cancer Survivors
Roberta Florido et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)
Atrial Fibrillation and Cancer Patients: Mechanisms and Management
David L. Madnick et al.
CURRENT CARDIOLOGY REPORTS (2022)
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC)
Alexander R. Lyon et al.
EUROPEAN HEART JOURNAL (2022)
Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma
Kristen M. Sanfilippo et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2022)
Network meta-analysis of efficacy and safety of chlorthalidone and hydrochlorothiazide in hypertensive patients
Stela Dineva et al.
BLOOD PRESSURE MONITORING (2021)
Atrial Fibrillation and Cancer
Ludhmila Abrahao Hajjar et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Ibrutinib's off-target mechanism: cause for dose optimization
Sara M. Zimmerman et al.
CANCER BIOLOGY & THERAPY (2021)
Effects of hypertension on cancer survival: A meta-analysis
Fausto Petrelli et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)
New Concept of Onco-Hypertension and Future Perspectives
Satoshi Kidoguchi et al.
HYPERTENSION (2021)
Cancer Therapy-Associated Thrombosis
Steven P. Grover et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)
ALK inhibitor-induced bradycardia: A systematic-review and meta-analysis
Filipe Cirne et al.
LUNG CANCER (2021)
Heart Failure With Targeted Cancer Therapies Mechanisms and Cardioprotection
Virginia S. Hahn et al.
CIRCULATION RESEARCH (2021)
Hypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients
Daan C. H. van Dorst et al.
CIRCULATION RESEARCH (2021)
Cancer and atrial fibrillation: Epidemiology, mechanisms, and anticoagulation treatment
Danilo Menichelli et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2021)
Relationship between Hyperlipidemia, Cardiovascular Disease and Stroke: A Systematic Review
Aladeen Alloubani et al.
CURRENT CARDIOLOGY REVIEWS (2021)
A possible mechanism of hyperlipidemia in a patient with metastatic non-small cell lung cancer on lorlatinib therapy
Katherine McGee et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2021)
Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System: Effects and Modifications: A Scientific Statement From the American Heart Association
Tochi M. Okwuosa et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2021)
Beta-blockers in early-stage breast cancer: a systematic review and meta-analysis
R. Caparica et al.
ESMO OPEN (2021)
Symptomatic Sinus Bradycardia in a Patient with Solitary Fibrous Tumor/Hemangiopericytoma Treated with Pazopanib
Wataru Shioyama et al.
INTERNAL MEDICINE (2021)
Clinical Approach to Cardiovascular Toxicity of Oral Antineoplastic Agents JACC State-of-the-Art Review
Vijay U. Rao et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Cardiovascular Issues in Tyrosine Kinase Inhibitors Treatments for Chronic Myeloid Leukemia: A Review
Marco Santoro et al.
FRONTIERS IN PHYSIOLOGY (2021)
Effect of beta-blockers on survival of lung cancer patients: a systematic review and meta-analysis
Marisa Coelho et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2020)
Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial
Robert D. McBane et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Efficacy and Safety of Nonvitamin K Oral Anticoagulants in Patients with Atrial Fibrillation and Cancer: A Study-Level Meta-Analysis
Ilaria Cavallari et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
G. Curigliano et al.
ANNALS OF ONCOLOGY (2020)
Effectiveness of sacubitril-valsartan in cancer patients with heart failure
Ana Martin-Garcia et al.
ESC HEART FAILURE (2020)
Direct-acting oral anticoagulant use at extremes of body weight: Literature review and recommendations
Kelly Covert et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2020)
Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agents
Robert F. Cornell et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from theCardio-OncologyStudyGroup of theHeartFailureAssociation of theEuropeanSociety ofCardiology in collaboration with theInternationalCardio-OncologySociety
Alexander R. Lyon et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
An Update on the Structure of hERG
Andrew Butler et al.
FRONTIERS IN PHARMACOLOGY (2020)
Beta-adrenergic receptor blockers and liver cancer mortality in a national cohort of hepatocellular carcinoma patients
Ruzan Udumyan et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2020)
Impact of statin use on cancer-specific mortality and recurrence A meta-analysis of 60 observational studies
Jing Yang et al.
MEDICINE (2020)
The Risk of Arterial Thrombosis in Patients With Chronic Myeloid Leukemia Treated With Second and Third Generation BCR-ABL Tyrosine Kinase Inhibitors May Be Explained by Their Impact on Endothelial Cells: An In-Vitro Study
Helene Haguet et al.
FRONTIERS IN PHARMACOLOGY (2020)
Primary thromboprophylaxis in ambulatory cancer patients with a high Khorana score: a systematic review and meta-analysis
Floris T. M. Bosch et al.
BLOOD ADVANCES (2020)
Calcium Channel Blocker Nifedipine Suppresses Colorectal Cancer Progression and Immune Escape by Preventing NFAT2 Nuclear Translocation
Ling Wu et al.
CELL REPORTS (2020)
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
Craig T. January et al.
CIRCULATION (2019)
Cardio-Oncology: Vascular and Metabolic Perspectives A Scientific Statement From the American Heart Association
Umberto Campia et al.
CIRCULATION (2019)
Thalidomide-induced sinus bradycardia in Crohn's disease: case report and literature review
Menghui Liu et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2019)
Trametinib-Associated Bradycardia
Luai Alhazmi et al.
AMERICAN JOURNAL OF THERAPEUTICS (2019)
Involvement of Platelets in Cancers
Diane Mege et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2019)
Comparative efficacy and safety of chlorthalidone and hydrochlorothiazide-meta-analysis
Stela Dineva et al.
JOURNAL OF HUMAN HYPERTENSION (2019)
Adverse effects of dasatinib on glucose-lipid metabolism in patients with chronic myeloid leukaemia in the chronic phase
Lu Yu et al.
SCIENTIFIC REPORTS (2019)
The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis
Frits I. Mulder et al.
HAEMATOLOGICA (2019)
Monitoring the heart during cancer therapy
Mohsen Habibian et al.
EUROPEAN HEART JOURNAL SUPPLEMENTS (2019)
Therapeutic Inhibition of VEGF Signaling and Associated Nephrotoxicities
Chelsea C. Estrada et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
Marc Carrier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Apixaban for the prevention of thromboembolism in immunomodulatory-treated myeloma patients: Myelaxat, a phase 2 pilot study
Brigitte Pegourie et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Cardiovascular Adverse Events Associated With BRAF and MEK Inhibitors A Systematic Review and Meta-analysis
Raluca I. Mincu et al.
JAMA NETWORK OPEN (2019)
Cardiovascular Disease and Breast Cancer: Where These Entities Intersect A Scientific Statement From the American Heart Association
Laxmi S. Mehta et al.
CIRCULATION (2018)
Everolimus as cancer therapy: Cardiotoxic or an unexpected antiatherogenic agent? A narrative review
Georgios Karvelas et al.
HELLENIC JOURNAL OF CARDIOLOGY (2018)
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
Annie M. Young et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
Gary E. Raskob et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Anticancer drugs-related QTc prolongation, torsade de pointes and sudden death: current evidence and future research perspectives
Jialin Duan et al.
Oncotarget (2018)
Association between insulin resistance and the development of cardiovascular disease
Valeska Ormazabal et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study
Giancarlo Agnelli et al.
THROMBOSIS AND HAEMOSTASIS (2018)
Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment
Norbaini Binti Abdol Razak et al.
CANCERS (2018)
Angiotensin receptor blocker use and gastro-oesophageal cancer survival: a population-based cohort study
J. Busby et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Risk of Arterial Thromboembolism in Patients With Cancer
Babak B. Navi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Use of direct oral anticoagulants in patients on immunomodulatory agents
L. Man et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2017)
Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review
Andreu Porta-Sanchez et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Precision cardio-oncology: understanding the cardiotoxicity of cancer therapy
Xinqiang Han et al.
NPJ PRECISION ONCOLOGY (2017)
Cardiovascular Effects of the MEK Inhibitor, Trametinib: A Case Report, Literature Review, and Consideration of Mechanism
Mary Banks et al.
CARDIOVASCULAR TOXICOLOGY (2017)
Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN)
Edith Pituskin et al.
BMC CANCER (2016)
Beta blockers and cancer prognosis - The role of immortal time bias: A systematic review and meta-analysis
Janick Weberpals et al.
CANCER TREATMENT REVIEWS (2016)
Concepts in cardio-oncology: definitions, mechanisms, diagnosis and treatment strategies of cancer therapy-induced cardiotoxicity
Chanaka D. Wickramasinghe et al.
FUTURE ONCOLOGY (2016)
Thromboprophylaxis in multiple myeloma patients treated with lenalidomide - A systematic review
Fatimah Al-Ani et al.
THROMBOSIS RESEARCH (2016)
Cholesterol lowering: role in cancer prevention and treatment
Toshiyuki Murai
BIOLOGICAL CHEMISTRY (2015)
Effects of ACEIs Versus ARBs on Proteinuria or Albuminuria in Primary Hypertension A Meta-Analysis of Randomized Trials
Rui Xu et al.
MEDICINE (2015)
International Myeloma Working Group Consensus Statement for the Management, Treatment, and Supportive Care of Patients With Myeloma Not Eligible for Standard Autologous Stem-Cell Transplantation
Antonio Palumbo et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Mechanism of impaired glucose metabolism during nilotinib therapy in patients with chronic myelogenous leukemia
Zdenek Racil et al.
HAEMATOLOGICA (2013)
27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology
Erik R. Nelson et al.
SCIENCE (2013)
Exposure to ACEI/ARB and β-Blockers Is Associated with Improved Survival and Decreased Tumor Progression and Hospitalizations in Patients with Advanced Colon Cancer
Diana R. Engineer et al.
TRANSLATIONAL ONCOLOGY (2013)
Cholesterol and prostate cancer
Kristine Pelton et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
Treatment of bevacizumab-induced hypertension by amlodipine
Olivier Mir et al.
INVESTIGATIONAL NEW DRUGS (2012)
Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial
Antonio Palumbo et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Peripheral edema associated with calcium channel blockers: incidence and withdrawal rate - a meta-analysis of randomized trials
Harikrishna Makani et al.
JOURNAL OF HYPERTENSION (2011)
Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status
Terry K. W. Ma et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and management
Hassane Izzedine et al.
EUROPEAN JOURNAL OF CANCER (2010)
Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors
Michael L. Maitland et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Bexarotene Induces Dyslipidemia by Increased Very Low-Density Lipoprotein Production and Cholesteryl Ester Transfer Protein-Mediated Reduction of High-Density Lipoprotein
Jitske de Vries-van der Weij et al.
ENDOCRINOLOGY (2009)
Assessing Risk of Venous Thromboembolism in the Patient With Cancer
Alok A. Khorana et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Mitigation of calcium channel blocker-related oedema in hypertension by antagonists of the renin-angiotensin system
A. de la Sierra
JOURNAL OF HUMAN HYPERTENSION (2009)
Cardiovascular Complications of Cancer Therapy Incidence, Pathogenesis, Diagnosis, and Management
Edward T. H. Yeh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Common risk factors for both arterial and venous thrombosis
Gordon D. O. Lowe
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics
Ming Hui Chen et al.
CIRCULATION (2008)
The association between statins and cancer incidence in a veterans population
Wildon R. Farwell et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Prognostic importance of Comorbidity in a hospital-based cancer registry
JF Piccirillo et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer
AYY Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Risk factors for venous thromboembolism
FA Anderson et al.
CIRCULATION (2003)
Share Paper
